Evidence map›Paper›PMID 33036496›Full record

ReviewMolecules (Basel, Switzerland)2020

Natural Compound-derived Cytochrome bc1 Complex Inhibitors as Antifungal Agents.

Loana Musso, Andrea Fabbrini, Sabrina Dallavalle

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Loana MussoDepartment of Food, Environmental and Nutritional Sciences (DeFENS), Division of Chemical and Biomolecular Sciences, Università degli Studi di Milano, Via Celoria 2, 20133, Milan, Italy.ORCID 0000-0002-6838-7753
Andrea FabbriniDepartment of Food, Environmental and Nutritional Sciences (DeFENS), Division of Chemical and Biomolecular Sciences, Università degli Studi di Milano, Via Celoria 2, 20133, Milan, Italy.
Sabrina DallavalleDepartment of Food, Environmental and Nutritional Sciences (DeFENS), Division of Chemical and Biomolecular Sciences, Università degli Studi di Milano, Via Celoria 2, 20133, Milan, Italy.ORCID 0000-0002-8813-8922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high incidence of fungal pathogens has become a global issue for crop protection. A promising strategy to control fungal plant infections is based on the use of nature-inspired compounds. The cytochrome bc1 complex is an essential component of the cellular respiratory chain and is one of the most important fungicidal targets. Natural products have played a crucial role in the discovery of cytochrome bc1 inhibitors, as proven by the development of strobilurins, one of the most important classes of crop-protection agents, over the past two decades. In this review, we summarize advances in the exploration of natural product scaffolds for the design and development of new bc1 complex inhibitors. Particular emphasis is given to molecular modeling-based approaches and structure-activity relationship (SAR) studies performed to improve the stability and increase the potency of natural precursors. The collected results highlight the versatility of natural compounds and provide an insight into the potential development of nature-inspired derivatives as antifungal agents.

Indexed as

Antifungal AgentsElectron Transport Complex IIIStrobilurinsStructure-Activity RelationshipAntifungal AgentsElectron Transport Complex IIIStrobilurinsantifungalscytochrome bc1 complex(E)-β-methoxyacrylatenatural compoundsstrobilurins

Identifiers

PMID33036496
PMCPMC7583968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.